{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:21:22Z","timestamp":1707524482322},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,24]]},"DOI":"10.7759\/cureus.23470","type":"journal-article","created":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T02:49:16Z","timestamp":1648176556000},"source":"Crossref","is-referenced-by-count":2,"title":["Emergence of Chronic Lymphocytic Leukemia During Admission for COVID-19: Cause or Coincidence?"],"prefix":"10.7759","author":[{"given":"Prachi","family":"Saluja","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitesh","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FNU","family":"Amisha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mazin","family":"Safar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thaddeus","family":"Bartter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020008824","article-title":"Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients","volume":"136","author":"Vijenthira A","year":"2020","unstructured":"Vijenthira A, Gong IY, Fox TA, et al.. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients. Blood. 2020, 136:2881-92. 10.1182\/blood.2020008824","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-09-806398","article-title":"iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL","volume":"131","author":"Hallek M","year":"2018","unstructured":"Hallek M, Cheson BD, Catovsky D, et al.. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. Blood. 2018, 131:2745-60. 10.1182\/blood-2017-09-806398","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-08-044008","article-title":"Respiratory tract infections and subsequent risk of chronic lymphocytic leukemia","volume":"109","author":"Landgren O","year":"2007","unstructured":"Landgren O, Rapkin JS, Caporaso NE, Mellemkjaer L, Gridley G, Goldin LR, Engels EA. Respiratory tract infections and subsequent risk of chronic lymphocytic leukemia. Blood. 2007, 109:2198-201. 10.1182\/blood-2006-08-044008","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06859.x","article-title":"Acquired immune-related and inflammatory conditions and subsequent chronic lymphocytic leukaemia","volume":"139","author":"Landgren O","year":"2007","unstructured":"Landgren O, Gridley G, Check D, Caporaso NE, Morris Brown L. Acquired immune-related and inflammatory conditions and subsequent chronic lymphocytic leukaemia. Br J Haematol. 2007, 139:791-8. 10.1111\/j.1365-2141.2007.06859.x","journal-title":"Br J Haematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07849.x","article-title":"Common community acquired infections and subsequent risk of chronic lymphocytic leukaemia","volume":"147","author":"Anderson LA","year":"2009","unstructured":"Anderson LA, Landgren O, Engels EA. Common community acquired infections and subsequent risk of chronic lymphocytic leukaemia. Br J Haematol. 2009, 147:444-9. 10.1111\/j.1365-2141.2009.07849.x","journal-title":"Br J Haematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2018.03.012","article-title":"T cell dysfunction in cancer","volume":"33","author":"Thommen DS","year":"2018","unstructured":"Thommen DS, Schumacher TN. T cell dysfunction in cancer. Cancer Cell. 2018, 33:547-62. 10.1016\/j.ccell.2018.03.012","journal-title":"Cancer Cell"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.926062","article-title":"Chronic lymphocytic leukemia concomitant with COVID 19: a case report","volume":"21","author":"Ali E","year":"2020","unstructured":"Ali E, Badawi M, Abdelmahmuod E, Kohla S, Yassin MA. Chronic lymphocytic leukemia concomitant with COVID 19: a case report. Am J Case Rep. 2020, 21:e926062. 10.12659\/AJCR.926062","journal-title":"Am J Case Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2020.36.286.24361","article-title":"COVID-19 and fortuitous discovery of chronic lymphocytic leukemia: biological findings and therapeutic challenges","volume":"36","author":"Charra B","year":"2020","unstructured":"Charra B, Ellouadghiri A, Magramane A, et al.. COVID-19 and fortuitous discovery of chronic lymphocytic leukemia: biological findings and therapeutic challenges. Pan Afr Med J. 2020, 36:1-5. 10.11604\/pamj.2020.36.286.24361","journal-title":"Pan Afr Med J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/jha2.52","article-title":"High percentage of smudge cells in a patient with COVID19: rediscovering their utility","volume":"1","author":"Jerez J","year":"2020","unstructured":"Jerez J, Ernst DM. High percentage of smudge cells in a patient with COVID19: rediscovering their utility. eJHaem. 2020, 1:374-5. 10.1002\/jha2.52","journal-title":"eJHaem"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.13383","article-title":"Major rise of a chronic lymphoid leukemia clone during the course of COVID-19","volume":"43","author":"Largeaud L","year":"2021","unstructured":"Largeaud L, Ribes A, Dubois-Galopin F, et al.. Major rise of a chronic lymphoid leukemia clone during the course of COVID-19. Int J Lab Hematol. 2021, 43:e82-3. 10.1111\/ijlh.13383","journal-title":"Int J Lab Hematol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2020.106366","article-title":"Covid-19 infection in therapy-naive patients with B-cell chronic lymphocytic leukemia","volume":"93","author":"Paneesha S","year":"2020","unstructured":"Paneesha S, Pratt G, Parry H, Moss P. Covid-19 infection in therapy-naive patients with B-cell chronic lymphocytic leukemia. Leuk Res. 2020, 93:106366. 10.1016\/j.leukres.2020.106366","journal-title":"Leuk Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/90890-emergence-of-chronic-lymphocytic-leukemia-during-admission-for-covid-19-cause-or-coincidence","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:42:39Z","timestamp":1707507759000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/90890-emergence-of-chronic-lymphocytic-leukemia-during-admission-for-covid-19-cause-or-coincidence"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,24]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.23470","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,24]]}}}